OPTN and glaucoma: In addition, several transgenic mice were created based on already discovered mutations in glaucoma patients, e.g., mutations in the genes MYOC/GLC1A, OPTN/GLC1E, and the tryptophan-aspartic acid repeat domain 36 (GLC1G) [47–52].